PTEN and gastric cancer: A study using PDX models of gastric cancer found that a single dose of the pan-AKT kinase inhibitor AZD5363 inhibited the growth of SGC100 PDX harboring the PI3KCA H1047R activation mutation by 60%, whereas only 23% inhibition was seen in the SGC020 PDX model with PTEN deficiency.